Acupuncture treatments will be included for the first time in Canada as a supplementary benefit for Medical Services Plan (MSP) premium assistance recipients by April 2008, Health Minister George Abbott announced.
Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September_26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune™. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of Revimmune, the company’s potential therapeutic for refractory, relapsing-remitting Multiple Sclerosis (MS).
UK Health Secretary Alan Johnson today announced a substantial £170 million expansion of psychological therapies to provide better support for people with mental health problems such as anxiety and depression.
People from all over US are being urged to join in October’s breast cancer awareness month by holding events in their communities to raise awareness and money for the cancer information charity Cancerbackup.
UK Public Health Minister Dawn Primarolo set out the way ahead for the Human Tissue and Embryology (HTE) bill by publishing the Government’s response to the Scrutiny Committee report on the bill. The bill represents a major overhaul of the law on assisted human reproduction and embryo research.
One of the largest studies to investigate the relationship between blood pressure and type 2 diabetes has found that women who have high blood pressure levels are three times more likely to develop diabetes than women with low blood pressure levels. This effect was independent of body mass index and other conditions that are known to predispose people to cardiovascular disease and diabetes.
Mayo Clinic researchers have found that a human antibody administered in a single low dose in laboratory mouse models can repair myelin, the insulating covering of nerves that when damaged can lead to multiple sclerosis and other disorders of the central nervous system.
Researchers have discovered a key protein that controls how stem cells “choose” to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published today in the Proceedings of the National Academy of Sciences (PNAS).
Hartmut “Hucky” Land, Ph.D., professor and chair of the Department of Biomedical Genetics, will give a talk titled “Construction and Deconstruction of Cancer Cells,” as part of a lecture series highlighting biological and biomedical research at the University of Rochester.
Patients and physicians are invited to a Lupus Education Day to learn more about an oft-misunderstood disease, but one for which several potential new treatments are in development.